Resultados da pesquisa - safety after last ((phase rate) OR (phase role))

Pesquisas alternativas:
after last » after blast (Expandir a Pesquisa), after laser (Expandir a Pesquisa), after lasik (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase re (Expandir a Pesquisa)
phase role » phase rule (Expandir a Pesquisa), phase route (Expandir a Pesquisa), phase whole (Expandir a Pesquisa)

1

Phase 1A safety assessment of intravenous amitriptyline

Phase 1A safety assessment of intravenous amitriptyline

Por Fridrich, Peter, Colvin, Hans Peter, Zizza, Anthony, Wasan, Ajay D., Lukanich, Jean, Lirk, Philipp, Saria, Alois, Zernig, Gerald, Hamp, Thomas, Gerner, Peter
Publicado em 2007

“... effects of preoperative intravenous amitriptyline in a typical phase 1A trial. After obtaining written...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib: an international, multicentre, prospective, randomised, placebo-controlled phase 3 trial (GRID)

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure...

Por Demetri, George D, Reichardt, Peter, Kang, Yoon-Koo, Blay, Jean-Yves, Rutkowski, Piotr, Gelderblom, Hans, Hohenberger, Peter, Leahy, Michael, von Mehren, Margaret, Joensuu, Heikki, Badalamenti, Giuseppe, Blackstein, Martin, Cesne, Axel Le, Schöffski, Patrick, Maki, Robert G, Bauer, Sebastian, Nguyen, Binh Bui, Xu, Jianming, Nishida, Toshirou, Chung, John, Kappeler, Christian, Kuss, Iris, Laurent, Dirk, Casali, Paolo
Publicado em 2012

“... and safety of regorafenib in patients with metastatic and/or unresectable GIST progressing after failure...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials

Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip...

Por Kawai, Yohko, Fuji, Takeshi, Fujita, Satoru, Kimura, Tetsuya, Ibusuki, Kei, Abe, Kenji, Tachibana, Shintaro
Publicado no Thromb J (2016)

“... with enoxaparin on key coagulation biomarkers and present pooled primary efficacy and safety results from phase 3...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

IMPACTS OF GROUP-BASED SIGNAL CONTROL POLICY ON DRIVER BEHAVIOR AND INTERSECTION SAFETY

IMPACTS OF GROUP-BASED SIGNAL CONTROL POLICY ON DRIVER BEHAVIOR AND INTERSECTION SAFETY

Por Keshuang TANG
Publicado em 2008-01-01

Assuntos: “...Intersection safety...”
Obter o texto integral

Artigo

5

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Por Langley, Joanne M., Carmona Martinez, Alfonso, Chatterjee, Archana, Halperin, Scott A., McNeil, Shelly, Reisinger, Keith S., Aggarwal, Naresh, Huang, Li-Min, Peng, Ching-Tien, Garcia-Sicilia, José, Salamanca de la Cueva, Ignacio, Cabañas, Fernando, Treviño-Garza, Consuelo, Rodríguez-Weber, Miguel Angel, de la O, Manuel, Chandrasekaran, Vijayalakshmi, Dewé, Walthère, Liu, Aixue, Innis, Bruce L., Jain, Varsha K.
Publicado em 2013

“... strains (A/H3N2 and A/H1N1) based on hemagglutination-inhibition (HI) antibodies 28 days after last...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Therapeutic effect and safety of laparoscopic cervical cerclage for treatment of cervical insufficiency in first trimester or non-pregnant phase

Therapeutic effect and safety of laparoscopic cervical cerclage for treatment of cervical insufficiency in first trimester or non-pregnant phase

Por Chen, Yuqing, Liu, Huashan, Gu, Jiayu, Yao, Shuzhong
Publicado no Int J Clin Exp Med (2015)

“... of pregnancy, the postoperative full term delivery rate, fetal salvage rate (if pregnancy lasted ≥ 14 weeks...”
Obter o texto integral
Obter o texto integral

Artigo

7

Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies

Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping...

Por Burri, Christian, Yeramian, Patrick D., Allen, James L., Merolle, Ada, Serge, Kazadi Kyanza, Mpanya, Alain, Lutumba, Pascal, Mesu, Victor Kande Betu Ku, Bilenge, Constantin Miaka Mia, Lubaki, Jean-Pierre Fina, Mpoto, Alfred Mpoo, Thompson, Mark, Munungu, Blaise Fungula, Manuel, Francisco, Josenando, Théophilo, Bernhard, Sonja C., Olson, Carol A., Blum, Johannes, Tidwell, Richard R., Pohlig, Gabriele
Publicado no PLoS Negl Trop Dis (2016)

“.... We conducted two Phase 2 studies to determine the efficacy and safety of oral pafuramidine in African...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

Por Oriol De Fabregues, Jaume Viñas, Antoni Palasí, Manuel Quintana, Ignasi Cardona, Cristina Auger, Víctor Vargas
Publicado em 2020-05-01

Assuntos: “...safety...”
Obter o texto integral

Artigo

9

Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study

Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study

Por Callahan, Margaret K., Kluger, Harriet, Postow, Michael A., Segal, Neil H., Lesokhin, Alexander, Atkins, Michael B., Kirkwood, John M., Krishnan, Suba, Bhore, Rafia, Horak, Christine, Wolchok, Jedd D., Sznol, Mario
Publicado no J Clin Oncol (2018)

“... patient who had multiorgan failure 70 days after the last dose of NIVO plus IPI. CONCLUSION...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

Por Hurvitz, Sara A., Gonçalves, Anthony, Rugo, Hope S., Lee, Kyung‐Hun, Fehrenbacher, Louis, Mina, Lida A., Diab, Sami, Blum, Joanne L., Chakrabarti, Jayeta, Elmeliegy, Mohamed, DeAnnuntis, Liza, Gauthier, Eric, Czibere, Akos, Tudor, Iulia Cristina, Quek, Ruben G.W., Litton, Jennifer K., Ettl, Johannes
Publicado no Oncologist (2019)

“...BACKGROUND: In the EMBRACA phase III study (NCT01945775), talazoparib was associated with a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

1371. Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TP-6076, a Novel, Fully Synthetic Tetracycline, in a Phase 1 Study

1371. Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TP-6076, a Novel, Fully Synthetic Tetracycline, in a Phase 1 Study

Por Tsai, Larry, Moore, Alison
Publicado no Open Forum Infect Dis (2018)

“... collected starting immediately prior to dosing until 96 hours after the last dose. Safety was assessed...”
Obter o texto integral
Obter o texto integral

Artigo

12

Checkpoint Inhibition in Hodgkin’s Lymphoma – Saving the Best for Last?

Checkpoint Inhibition in Hodgkin’s Lymphoma – Saving the Best for Last?

Por Lin, Richard J., Diefenbach, Catherine S.
Publicado no Oncology (Williston Park) (2016)

“... with these mechanistic studies, early phase clinical trials using the checkpoint inhibitors nivolumab and pembrolizumab...”
Obter o texto integral
Obter o texto integral

Artigo

13

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced...

Por Fuchs, Charles S., Doi, Toshihiko, Jang, Raymond W., Muro, Kei, Satoh, Taroh, Machado, Manuela, Sun, Weijing, Jalal, Shadia I., Shah, Manish A., Metges, Jean-Phillipe, Garrido, Marcelo, Golan, Talia, Mandala, Mario, Wainberg, Zev A., Catenacci, Daniel V., Ohtsu, Atsushi, Shitara, Kohei, Geva, Ravit, Bleeker, Jonathan, Ko, Andrew H., Ku, Geoffrey, Philip, Philip, Enzinger, Peter C., Bang, Yung-Jue, Levitan, Diane, Wang, Jiangdian, Rosales, Minori, Dalal, Rita P., Yoon, Harry H.
Publicado no JAMA Oncol (2018)

“... has progressed after 2 or more lines of therapy. OBJECTIVE: To evaluate the safety and efficacy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years...

Por Burmester, Gerd R, Matucci-Cerinic, Marco, Mariette, Xavier, Navarro-Blasco, Francisco, Kary, Sonja, Unnebrink, Kristina, Kupper, Hartmut
Publicado em 2014

“... to continue treatment for 5 years in ReAlise. The purpose of this study was to evaluate the long-term safety...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a...

Por Breedt, Johannes, Teras, Jüri, Gardovskis, Janis, Maritz, Frans Jacobus, Vaasna, Tiit, Ross, Douglas Patrick, Gioud-Paquet, Martine, Dartois, Nathalie, Ellis-Grosse, Evelyn J., Loh, Evan
Publicado em 2005

“... visit 12 to 92 days after the last dose. The microbiologic response at the test-of-cure visit was also...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

Por Kim, Jae‐Joon, Ryu, Min‐Hee, Yoo, Changhoon, Beck, Mo Youl, Ma, Jung Eun, Kang, Yoon‐Koo
Publicado no Oncologist (2019)

“... control rate (DCR: complete response plus partial response [PR] plus stable disease [SD]) lasting...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label Phase 2 Trial

Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label Phase 2 Trial

Por Jones, Jeffrey A., Mato, Anthony R., Wierda, William G., Davids, Matthew S., Choi, Michael, Cheson, Bruce D., Furman, Richard R., Lamanna, Nicole, Barr, Paul M., Zhou, Lang, Chyla, Brenda, Salem, Ahmed Hamed, Verdugo, Maria, Humerickhouse, Rod A., Potluri, Jalaja, Coutre, Steven, Woyach, Jennifer, Byrd, John C.
Publicado no Lancet Oncol (2017)

“... the efficacy and safety of venetoclax monotherapy. Efficacy was measured by overall response rate, defined...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients...

Por Martin-Broto, Javier, Hindi, Nadia, Lopez-Pousa, Antonio, Peinado-Serrano, Javier, Alvarez, Rosa, Alvarez-Gonzalez, Ana, Italiano, Antoine, Sargos, Paul, Cruz-Jurado, Josefina, Isern-Verdum, Josep, Dolado, Maria Carmen, Rincon-Pérez, Inmaculada, Sanchez-Bustos, Paloma, Gutierrez, Antonio, Romagosa, Cleofe, Morosi, Carlo, Grignani, Giovanni, Gatti, Marco, Luna, Pablo, Alastuey, Ignacio, Redondo, Andres, Belinchon, Belen, Martinez-Serra, Jordi, Sunyach, Marie-Pierre, Coindre, Jean-Michel, Dei Tos, Angelo P., Romero, Jesus, Gronchi, Alessandro, Blay, Jean-Yves, Moura, David S.
Publicado no JAMA Oncol (2020)

“...) and the overall response rate (phase 2) with use of trabectedin plus irradiation in metastatic soft-tissue...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial

2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine...

Por Vink, Peter, Torrell, Josep Maria Ramon, Sanchez-Fructuoso, Ana I, Kim, Sung-Joo, Kim, Sang Il, Zaltzman, Jeffrey, Ortiz, Fernanda, Plana, Josep Maria Campistol, Rodriguez, Ana Maria Fernandez, Rodrigo, Henar Rebollo, Marti, Magda Campins, Perez, Rafael, González-Roncero, Francisco Manuel, Kumar, Deepali, Chiang, Yang-Jen, Doucette, Karen, Pipeleers, Lissa, Morales, Maria Luisa Agüera, Ferrero, Maria Luisa Rodriguez, Secchi, Antonio, McNeil, Shelly A, Campora, Laura, Paolo, Emmanuel Di, Idrissi, Mohamed El, López-Fauqued, Marta, Salaun, Bruno, Heineman, Thomas, Oostvogels, Lidia
Publicado no Open Forum Infect Dis (2018)

“... post-last dose safety and immune persistence data are presented. METHODS: In this phase III, 1:1...”
Obter o texto integral
Obter o texto integral

Artigo

20

A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis

A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin...

Por Connolly, Lynn E., Riddle, Valerie, Cebrik, Deborah, Armstrong, Eliana S., Miller, Loren G.
Publicado no Antimicrob Agents Chemother (2018)

“... evaluated the efficacy and safety of plazomicin in a double-blind, comparator-controlled, phase 2 study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[11]